Post Subject #149   7/20 MannKind - Afrezza Television Ad Debuts - TREND1 07/20/17 05:09:36 PM #148   7/18 Earnings Preview: Valeant Pharmaceuticals TREND1 07/18/17 10:45:53 AM #147   7/17 Valeant: At Worst, A Good Catalyst Play TREND1 07/17/17 06:08:48 PM #146   7/17 Mixed Feelings About The $190 Million Obagi Sale TREND1 07/17/17 03:12:47 PM #145   7/14 MannKind - Afrezza Scripts Remain Above 300 TREND1 07/14/17 03:11:47 PM #143   7/12 Arena Announces Prospectus To Sell $150 Million TREND1 07/12/17 11:00:06 AM #142   7/11 So Many Promises And Now We Are TREND1 07/11/17 09:32:33 PM #141   7/11 JohnnyMoneymaker TREND1 07/11/17 03:47:14 PM #140   7/11 Arena Announces Positive Clinical Trial Results TREND1 07/11/17 10:40:27 AM #139   7/10 Spencer Osborne's Blog TREND1 07/10/17 05:51:20 PM #138   7/7 MannKind: Weekly Afrezza Scripts Leveling Off Above 300 TREND1 07/07/17 03:37:09 PM #136   7/2 A Micron Super Cycle? TREND1 07/02/17 09:21:42 PM #135   7/2 MannKind - Afrezza Scripts Come Back Down TREND1 07/02/17 10:56:54 AM #134   6/30 MannKind - Afrezza Scripts Come Back Down TREND1 06/30/17 11:58:52 AM #133   6/29 Micron Q3 beats estimates, OCF doubled on TREND1 06/29/17 04:52:17 PM #132   6/29 MannKind Renegotiates Debt Payment To Deerfield TREND1 06/29/17 02:41:59 PM #130   6/29 MannKind Maxes Out Its Last Credit Card TREND1 06/29/17 11:41:04 AM #128   6/27 Micron: I'm Betting Big TREND1 06/27/17 04:17:35 PM #127   6/26 Rite Aid: Merger Is Sunk TREND1 06/26/17 03:07:09 PM #126   6/25 Fred's and Rite Aid keep racing higher TREND1 06/26/17 03:04:33 PM #125   6/23 MannKind: Afrezza Sales See Best Result In TREND1 06/23/17 12:58:36 PM #124   6/19 MannKind: Afrezza Scripts Above 300 - Can TREND1 06/19/17 10:15:14 AM #123   ism data from WHS TREND1 06/16/17 01:33:28 PM #122   Shorts lose battles, but rarely lose the war TREND1 06/16/17 12:56:12 PM #121   Largest 50 companies by market cap TREND1 06/14/17 11:44:35 PM #120   6/14 Cash flow positive by Q4 2017 TREND1 06/14/17 05:18:01 PM #119   6/13 MannKind - Afrezza Adverse Events Data Q1 2017 TREND1 06/13/17 02:28:25 PM #118   6/13 MannKind Scripts Not Helping Cash Situation TREND1 06/13/17 01:46:04 PM #117   6/8 I do not see AFREZZA drop out TREND1 06/08/17 12:42:07 PM #116   6/6 The rejection rate for AFREZZA is 95.5 TREND1 06/06/17 10:51:26 PM #115   5/30/17 Hypi sees a buy out by AMGN TREND1 06/06/17 10:44:05 PM #114   6/4/17 tx_farmer You say $10 by 12/4/17 TREND1 06/06/17 10:30:41 PM #113   6/6/17 Hypi says $7 or $8 by 12/31/17 TREND1 06/06/17 10:27:43 PM #112   6/5 MannKind - Afrezza Scripts Dip As Company TREND1 06/05/17 09:08:08 PM #111   DATA TREND1 06/03/17 11:31:41 PM #110   5/31 MannKind Promotes New CEO - Will Strategy TREND1 05/31/17 11:04:18 AM #109   5/30 MannKind: Scripts Dip, But Stock Moves On Technicals TREND1 05/30/17 10:21:47 AM #108   5/23 MannKind Contract With Amphastar TREND1 05/23/17 04:56:47 PM #107   5/21 MannKind - Afrezza Adverse Events Since Launch TREND1 05/21/17 08:23:13 PM #106   5/19 Afrezza: What Is Possible Vs. What Is Probable TREND1 05/19/17 03:01:39 PM #105   5/18 Reading MannKind's SEC Documents Would Help Investors TREND1 05/18/17 02:13:29 PM #103   5/12 MannKind - Afrezza Script Sales Stable But Low TREND1 05/12/17 04:47:14 PM #101   5/12 Mannkind Q1: Nothing But Losses TREND1 05/12/17 11:44:45 AM #100   5/11 MannKind Reports Q1 Loss - What Investors TREND1 05/11/17 12:30:24 PM #99   5/11 MannKind Q1 revenue disappoints, shares down 15% TREND1 05/11/17 12:09:47 PM #98   5/10 MannKind's (MNKD) CEO Matthew Pfeffer on Q1 TREND1 05/10/17 11:40:17 PM #96   5/8 MannKind Making Moves, Could Gain Nasdaq Compliance TREND1 05/08/17 05:00:12 PM #95   5/5 MannKind: Afrezza Sales Still Low As Company TREND1 05/05/17 02:37:16 PM #94   5/2 MannKind Hopes To Reverse Fortunes With Television Show TREND1 05/02/17 04:27:46 PM #93   5/1 MannKind: Mann Trust Executors Are Selling Massive TREND1 05/01/17 02:57:13 PM Post Subject

© 2017 InvestorsHub.Com, Inc.